| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 824 | 2018 |
| Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array RA Eeles, AAA Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ... Nature genetics 45 (4), 385-391, 2013 | 680 | 2013 |
| A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer AA Al Olama, Z Kote-Jarai, SI Berndt, DV Conti, F Schumacher, Y Han, ... Nature genetics 46 (10), 1103-1109, 2014 | 532 | 2014 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 354 | 2021 |
| Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study Z Kote-Jarai, AAA Olama, GG Giles, G Severi, J Schleutker, M Weischer, ... Nature genetics 43 (8), 785-791, 2011 | 338 | 2011 |
| Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial CC Parker, NW Clarke, AD Cook, HG Kynaston, PM Petersen, C Catton, ... The Lancet 396 (10260), 1413-1421, 2020 | 316 | 2020 |
| Active surveillance for clinically localized prostate cancer––A systematic review FB Thomsen, K Brasso, LH Klotz, MA Røder, KD Berg, P Iversen Journal of surgical oncology 109 (8), 830-835, 2014 | 252 | 2014 |
| Tranexamic acid in patients undergoing noncardiac surgery PJ Devereaux, M Marcucci, TW Painter, D Conen, V Lomivorotov, ... New England Journal of Medicine 386 (21), 1986-1997, 2022 | 196 | 2022 |
| Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts TM Seibert, CC Fan, Y Wang, V Zuber, R Karunamuni, JK Parsons, ... bmj 360, 2018 | 186 | 2018 |
| A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease A Amin Al Olama, Z Kote-Jarai, FR Schumacher, F Wiklund, SI Berndt, ... Human molecular genetics 22 (2), 408-415, 2013 | 161 | 2013 |
| Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis B Malling, MA Røder, K Brasso, J Forman, M Taudorf, L Lönn European radiology 29, 287-298, 2019 | 135 | 2019 |
| The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium NM Davies, TR Gaunt, SJ Lewis, J Holly, JL Donovan, FC Hamdy, ... Cancer Causes & Control 26, 1603-1616, 2015 | 119 | 2015 |
| Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans A Amin Al Olama, T Dadaev, DJ Hazelett, Q Li, D Leongamornlert, ... Human molecular genetics 24 (19), 5589-5602, 2015 | 115 | 2015 |
| ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer KD Berg, B Vainer, FB Thomsen, MA Røder, TA Gerds, BG Toft, K Brasso, ... European urology 66 (5), 851-860, 2014 | 108 | 2014 |
| Does cytoreductive prostatectomy really have an impact on prognosis in prostate cancer patients with low-volume bone metastasis? Results from a prospective case-control study T Steuber, KD Berg, MA Røder, K Brasso, P Iversen, H Huland, A Tiebel, ... European urology focus 3 (6), 646-649, 2017 | 104 | 2017 |
| Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ... Nature communications 9 (1), 2256, 2018 | 101 | 2018 |
| Trends in incidence and 5‐year mortality in men with newly diagnosed, metastatic prostate cancer—A population‐based analysis of 2 national cohorts JT Helgstrand, MA Røder, N Klemann, BG Toft, DY Lichtensztajn, ... Cancer 124 (14), 2931-2938, 2018 | 87 | 2018 |
| Short-term morbidity and mortality following radical cystectomy: a systematic review SL Maibom, UN Joensen, AM Poulsen, H Kehlet, K Brasso, MA Røder BMJ open 11 (4), e043266, 2021 | 82 | 2021 |
| Prediction of individual genetic risk to prostate cancer using a polygenic score R Szulkin, T Whitington, M Eklund, M Aly, RA Eeles, D Easton, ... The Prostate 75 (13), 1467-1474, 2015 | 73 | 2015 |
| Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate FB Thomsen, MA Røder, P Rathenborg, K Brasso, M Borre, P Iversen Scandinavian journal of urology 48 (3), 268-275, 2014 | 73 | 2014 |
Klaus BrassoCopenhagen Prostate Cancer Center, Rigshospitalet.在 regionh.dk 的电子邮件经过验证
